SOURCE / PRESS RELEASE
China's Ultrasound Imaging Enters 'Micron Era' as VINNO Breaks Medical Equipment Bottlenecks
By Qi Chenjiong
Chinese medical equipment manufacturer VINNO has unveiled breakthrough ultrasound technology capable of imaging at the 10-micron level, marking a significant stride in the country's push to overcome critical bottlenecks in high-end medical devices.
At the 93rd China International Medical Equipment Fair (CMEF) held in Shanghai from April 9-12, the company showcased its ULTIMUS 9E system featuring URM Ultra-resolution Microscopy – the most advanced platform in VINNO's portfolio to date.
"Conventional ultrasound has long been constrained by diffraction limits, making it impossible to visualize peripheral nerve microvascular networks with sufficient resolution for early diagnosis," Tian Yuan, VINNO's co-founder, told the Global Times Online. "Our super-resolution technology tracks microbubble trajectories within micro vessels, breaking through these barriers to achieve quantitative analysis at the 10-micron scale."
The system enables precise quantification of more than 20 key clinical parameters, including microvascular density, blood flow velocity, and perfusion rates, supporting applications across the full diagnostic and treatment workflow.
VINNO has launched nearly 20 multicenter clinical studies involving 20 to 30 tertiary Grade A hospitals each, targeting conditions ranging from kidney disease and transplantation to Crohn's disease and various tumors. The company's "pre-research—validation—promotion" approach aims to accelerate clinical adoption of innovations.
After more than a decade specializing in ultrasound technology, VINNO has developed core proprietary platforms including soft beam synthesis and intelligent ultrasound systems. Its products are now distributed across over 100 countries and regions.
The company is also advancing what it terms "comprehensive real-time dynamic artificial intelligence" — an AI architecture integrated across the entire imaging chain from acoustic signal conversion through image generation. "We are committed to real-time video analysis from day one despite the technical challenges, because it ensures diagnostic objectivity," Tian explained.
VINNO is further exploring robotic ultrasound systems to standardize scanning procedures and enhance data acquisition precision, Tian added.
Chinese medical equipment manufacturer VINNO has unveiled breakthrough ultrasound technology capable of imaging at the 10-micron level, marking a significant stride in the country's push to overcome critical bottlenecks in high-end medical devices.
At the 93rd China International Medical Equipment Fair (CMEF) held in Shanghai from April 9-12, the company showcased its ULTIMUS 9E system featuring URM Ultra-resolution Microscopy – the most advanced platform in VINNO's portfolio to date.
"Conventional ultrasound has long been constrained by diffraction limits, making it impossible to visualize peripheral nerve microvascular networks with sufficient resolution for early diagnosis," Tian Yuan, VINNO's co-founder, told the Global Times Online. "Our super-resolution technology tracks microbubble trajectories within micro vessels, breaking through these barriers to achieve quantitative analysis at the 10-micron scale."
The system enables precise quantification of more than 20 key clinical parameters, including microvascular density, blood flow velocity, and perfusion rates, supporting applications across the full diagnostic and treatment workflow.
VINNO has launched nearly 20 multicenter clinical studies involving 20 to 30 tertiary Grade A hospitals each, targeting conditions ranging from kidney disease and transplantation to Crohn's disease and various tumors. The company's "pre-research—validation—promotion" approach aims to accelerate clinical adoption of innovations.
After more than a decade specializing in ultrasound technology, VINNO has developed core proprietary platforms including soft beam synthesis and intelligent ultrasound systems. Its products are now distributed across over 100 countries and regions.
The company is also advancing what it terms "comprehensive real-time dynamic artificial intelligence" — an AI architecture integrated across the entire imaging chain from acoustic signal conversion through image generation. "We are committed to real-time video analysis from day one despite the technical challenges, because it ensures diagnostic objectivity," Tian explained.
VINNO is further exploring robotic ultrasound systems to standardize scanning procedures and enhance data acquisition precision, Tian added.
